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Abstract
 
The paucity of lymph node T cells (
 
plt
 
) mutation leads to a loss of CCL21 and CCL19 expres-
sion in secondary lymphoid organs. 
 
plt
 
 mice have defects in the migration of naive T cells and
activated dendritic cells into the T cell zones of lymphoid organs, suggesting that they would
have defects in T cell immune responses. We now demonstrate T cell responses in 
 
plt
 
 mice are
delayed but ultimately enhanced. Responses to contact sensitization are decreased at day 2 after
priming but increased at day 6. After subcutaneous immunization, antigen-specific T cell pro-
liferation and cytokine production in 
 
plt
 
 mice are increased and remain markedly elevated for
at least 8 wk. Compared with wild-type mice, a proportion of T cell response in 
 
plt
 
 mice are
shifted to the spleen, and prior splenectomy reduces the T cell response in draining lymph
nodes. After immunization of 
 
plt
 
 mice, T cells and dendritic cells colocalize in the superficial
cortex of lymph nodes and in splenic bridging channels, but not in T cell zones. These results
demonstrate that 
 
plt
 
 mice mount robust T cell responses despite the failure of naive T cells and
activated dendritic cells to enter the thymus dependent areas of secondary lymphoid organs.
Key words: chemokines • cell migration • lymphoid tissue • immunomodulators • contact 
hypersensitivity
 
Introduction
 
Within the T cell zones of secondary lymphoid organs, a
continuous flow of naive T cells sample antigens presented
by dendritic cells (DCs).
 
1 
 
During an immune response, a
small percentage of these T cells will encounter their cog-
nate antigen in the context of MHC and costimulatory sig-
nals provided by DCs and cytokines present within the T
cell zone (1). This encounter initiates a series of changes in
the numbers, activities, and migration patterns of antigen-
specific T cells (2). It is believed that chemokines contrib-
ute to this process by controlling the localization of various
leukocyte subsets within lymphoid organs (3–6). Recent
studies have demonstrated the role of chemokines in sev-
eral leukocyte trafficking events thought to be important in
immune response (3, 7). However, the manner in which
leukocyte localization contributes to immune response re-
mains largely unknown.
 
Two constitutively expressed chemokines, CCL21 (for-
merly secondary lymphoid tissue chemokine [SLC]) and
CCL19 (formerly EBI1 ligand chemokine [ELC]), share a
common receptor, CC chemokine receptor (CCR)7 (8, 9).
CCL21 is expressed in the high endothelial venules (HEVs)
of LNs and Peyer’s patches (PPs), within the T cell zones of
LN, spleen, and PP, and in the lymphatic endothelium of
multiple tissues (10). Normal mice posses at least two inde-
 
pendent CCL21 genes, 
 
Scya21a
 
 and 
 
Scya21b
 
 (11, 12).
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Abbreviations used in this paper:
 
 BCECF, 2
 
9
 
,7
 
9
 
-bis(2-carboxyethyl)-
5(6)-carboxyfluorescein; CMFDA, 5-chloromethylfluorescein diacetate;
DC, dendritic cell; HEV, high endothelial venule; PCl, picryl chloride;
 
plt
 
, paucity of LN T cells; PP, Peyer’s patch; WT, wild-type. 
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T Cell Responses in 
 
plt
 
 Mice
 
Scya21a
 
 encodes a serine at position 65 of CCL21 (CCL21-
Ser) and is expressed in both secondary lymphoid organs
and lymphatics. The 
 
CCL21b
 
 gene, encoding leucine at
position 65 (CCL21-Leu), is expressed only in the lym-
phatic endothelium of peripheral tissues. CCL19 is ex-
pressed predominately by stromal cells within the T cell
zones of LN, spleen, and PP (13, 14). The receptor for
these ligands, CCR7, is expressed on all naive T cells, some
memory T cells, B cells, and activated DCs (15–18). Re-
ceptor occupancy by either ligand stimulates chemotaxis
and activation of leukocyte integrins (10, 19, 20).
We identified a spontaneous mutation in mice character-
ized by a defect in the homing of naive T cells to LNs, PPs,
and splenic white pulp (21, 22). This mutation, paucity of
LN T cells (
 
plt
 
), involves a genomic deletion that includes
the CCL21 gene expressed in lymphoid organs (
 
Scya21a
 
)
and the CCL19 gene (
 
Scya19
 
; references 11, 12, and 14). 
 
plt
 
mice do not express CCL21 or CCL19 protein in second-
ary lymphoid organs but continue to express CCL21 at re-
duced levels in lymphatic endothelium. 
 
plt
 
 mice have three
recognized defects in leukocyte localization. First, naive T
cells do not adhere to LN or PP HEVs of 
 
plt
 
 mice and
therefore display a near total loss of extravasation at these
sites (23, 24). This defect is thought to be due to a require-
ment for CCL21 in the activation of lymphocyte integrins
and can be partially reversed by treatment with exogenous
CCL21 (23). Naive T cell entry into splenic white pulp is
similarly affected. Second, 
 
plt
 
 mice demonstrate a marked
paucity of DCs within T cell zones and a decreased migra-
tion of activated DCs to the T cell zones of spleen and LNs
(25). Expression of CCR7 is induced in DCs upon activa-
tion, suggesting that CCL21 and/or CCL19 is involved in
the migration of these cells to T cell zones (15, 16). Third,
because CCL21 appears to contribute to the maintenance
of distinct T and B cell zones (26), 
 
plt
 
 mice demonstrate a
lack of recognizable T cell zones and an increased number
of T cells in and around lymphoid follicles (22).
Like 
 
plt
 
 mice, mice lacking CCR7 demonstrate dis-
rupted homing of naive T cells to T cell zones, decreased
migration of activated DCs from skin to LNs, and an ab-
normal distribution of T cells within secondary lymphoid
organs (27). The DC migration defect appears to be more
severe in CCR7
 
2
 
/
 
2
 
 mice than in 
 
plt
 
 mice, suggesting that
lymphatic expression of CCL21 is required for the migra-
tion of DC into lymphatics. CCR7
 
2
 
/
 
2
 
 mice demonstrate
delayed humoral responses to T cell–dependent antigens.
In models of contact hypersensitivity and delayed-type hy-
persensitivity, it has been reported that CCR7
 
2
 
/
 
2
 
 mice
lack primary T cell responses (27).
In our previous report, we observed that 
 
plt
 
 mice are
profoundly sensitive to infection with murine hepatitis vi-
rus (25). This finding, taken with the reported lack of T
cell responses in CCR7
 
2
 
/
 
2
 
 mice, strongly suggested that 
 
plt
 
mice would also be unable to develop primary T cell re-
sponses. In contrast to this prediction, we now demonstrate
that 
 
plt
 
 mice are capable of mounting robust T cell re-
sponses. The responses of 
 
plt
 
 mice to contact sensitization
and subcutaneous immunization are delayed, but ultimately
enhanced compared with that seen in wild-type (WT)
mice. More strikingly, Ag-specific T cell responses in the
LNs and spleens of 
 
plt
 
 mice do not decline after reaching
peak levels, suggesting that the activation of T cells within
the thymus dependent areas of secondary lymphoid organs
is required for the contraction phase of immune response.
 
Materials and Methods
 
Mice and Immunization.
 
BALB/c mice were purchased from
Shizuoka Laboratory Corporation and bred in the animal facilities
in Toho University School of Medicine. BALB/c-
 
plt/plt
 
 mice
were produced by back crossing DDD/1-
 
plt/plt
 
 mice to BALB/c
10 times and bred in the facilities. Mice were used at 8 to 12 wk
of age. They were immunized subcutaneously with 100 
 
m
 
g of
chicken OVA (Sigma-Aldrich) in a 1:1 emulsion of PBS and
CFA (Difco) in the footpads or at the base of the tail. In some ex-
periments, spleens were surgically removed from mice at least 9 d
before immunization.
 
Contact Hypersensitivity Response.
 
Mice were sensitized epicu-
taneously with 150 
 
m
 
l of 7% 2,4,5-trititrochlorobenzene (picryl
chloride [PCl]; Nacalai Tesque) in acetone/olive oil (4:1) on
their shaved abdomens. 2 or 6 d after sensitization, their right ears
were challenged with 20 
 
m
 
l 1% PCl in vehicle. As a control, their
left ears were challenged with vehicle alone. At various times af-
ter challenge, ear thickness was measured with a dial thickness
gauge (Peacock).
 
In Vitro Recall Response of T Cells.
 
Single cell suspensions
were prepared from draining popliteal and inguinal LNs or
spleens and pooled from 3–4 mice at 2–56 d after immunization.
Cells suspended in RPMI 1640 (Sigma-Aldrich) supplemented
with 10% FCS and 5 
 
3
 
 10
 
2
 
5
 
 M 2-ME were incubated with the
indicated concentrations with OVA in 96-well culture plates in
humidified atmosphere of 5% CO
 
2
 
 in air at 37
 
8
 
C for 4 d. The cell
proliferation was assessed by incorporation of [
 
3
 
H]TdR (Amer-
sham Pharmacia Biotech), which was determined on a Matrix 96
direct beta counter (Packard Instrument Co.) and the results were
expressed as counts/3 min. To assess IL-2 production, 50 
 
m
 
l of
culture supernatants were harvested at 24 h of culture, and IL-2
activity was determined using the IL-2–dependent T cell line,
CTLL-2. Proliferation of CTLL-2 was assessed as described
above. In some experiments, T cells were enriched from LN cells
by the passage through nylon wool column followed by the treat-
ment with anti–mouse IgM rabbit IgG and anti–MHC class II
mAb M5/114, and rabbit complement. The purity of CD3
 
1
 
 T
cells was 
 
.
 
95%. Enriched T cells were incubated with OVA in
the presence of 33 Gy x-ray–irradiated BALB/c spleen cells (5 
 
3
 
10
 
5
 
/well).
 
Flow Cytometric Analysis.
 
To analyze lymphocyte subpopula-
tions, cells were stained with appropriate mAbs conjugated with
FITC, PE, or biotin. Cells treated with biotinylated mAb were
further treated with PE-conjugated streptavidin. Anti–TCR-
 
a
 
/
 
b
 
(H57-597), anti-CD8 (53-6-7.2), anti-B220 (RA3-3A1/6.1),
anti–I-A
 
d
 
 (MK-D6), and anti-CD11c (N418) mAbs were used.
Stained cells were analyzed on Cytron Absolute (Ortho Diagnos-
tics) or FACSCalibur™ (Becton Dickinson) flow cytometers.
 
Histological Analysis.
 
9 d after immunization, draining pop-
liteal and inguinal LNs and spleen were harvested and frozen.
Cryostat sections (6 
 
m
 
m), preincubated with PBS containing 2%
rabbit serum and 1% BSA, were stained with FITC-conjugated
anti-Thy1.2 mAb (30H12), FITC-conjugated or biotinylated
anti-B220 mAb (RA3-3A1/6.1), or anti-DEC205 (NLDC-145)
followed by biotinylated rabbit anti–rat IgG (Jackson Immu- 
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noResearch Laboratories). For fluorescent analysis, biotinylated
Abs were followed by streptavidin-conjugated Cy3 (Jackson Im-
munoResearch Laboratories), and sections were analyzed on an
MRC-600 confocal laser microscope system (Bio-Rad Laborato-
ries). For immunohistochemical analysis, sections were stained
with horseradish peroxidase–conjugated rabbit anti-FITC Abs
(Dako) and streptavidin-conjugated alkaline phosphatase, devel-
oped with diaminobenzidine and VectorBlue (Vector Laborato-
ries).
 
In Vivo Migration Assay.
 
Resting lymphocytes were collected
from peripheral LNs, mesenteric LNs, and spleens of BALB/c
mice. Draining LN cells were collected from draining popliteal
and inguinal LNs of OVA/CFA-immunized BALB/c mice at day
9 after immunization. T cells were enriched by panning in goat
anti–mouse IgG (Cappel)-coated dishes followed by anti–MHC
class II (M5/114) and rabbit complement. T cell–enriched prepa-
ration always contained 
 
.
 
90% CD3
 
1
 
 cells. To purify activated
splenic T cells, splenocytes from BALB/c mice immunized with
OVA/CFA were sorted using MACS column (Miltenyi Biotec)
with anti-B220 (RA3-6B2), anti–I-A
 
d
 
 (39-10-8), anti-GR1
(RB6-8C5), and anti-CD45RB (16A) Abs (BD PharMingen).
Over 99% of enriched splenic T cells were CD44
 
high
 
 and 75%
were CD62L
 
low
 
. 10
 
6 
 
or 1.4 
 
3 
 
10
 
6 
 
2
 
9
 
,7
 
9
 
-bis(2-carboxyethyl)-5(6)-
carboxyfluorescein (BCECF)-AM (Dojindo)– or 5-chlorometh-
ylfluorescein diacetate (CMFDA; Molecular Probe)-loaded T
cells were injected by tail vein or subcutaneously into a foot pad
of untreated or OVA/CFA immunized mice at day 9 after immu-
nization. Mice were killed 6 h after injection, and BCECF- or
CMFDA-positive cells in draining (popliteal and inguinal) LNs
and nondraining (cervical, axillary, and brachial) LNs were quan-
titated by flow cytometry.
 
Results
 
Contact Hypersensitivity Response in plt/plt Mice.
 
WT
and 
 
plt
 
 mice were sensitized with PCl by abdominal skin
painting, and ear swelling was assessed upon rechallenge
with antigen. When rechallenged 2 d after sensitization, 
 
plt
 
mice demonstrate a reduced degree of ear swelling at 24 h
compared with that of WT mice (Fig. 1 A). However, in
contrast to what is normally seen in this assay, ear swelling
in 
 
plt
 
 mice increases rather than decreases over subsequent
days, such that it is greater than that seen in WT mice by
day 3 after rechallenge. When rechallenged 6 d after the
sensitizing dose, 
 
plt
 
 mice demonstrate an enhanced re-
sponse compared with WT mice at all time points exam-
ined. This response is rapid, and ear swelling decreases over
subsequent days. This finding suggests that T cell priming is
intact in 
 
plt 
 
mice although it is delayed relative to WT
mice.
 
Changes in Lymphocyte and DC Numbers after Immuniza-
tion. plt
 
 mice have a defect in the migration of naive T
cells and DCs to the T cell zones of LNs and spleen that
would seem to preclude effective T cell priming (21, 22,
25). The response of 
 
plt
 
 mice to contact sensitization sug-
gests that this defect may be overcome after antigen chal-
lenge. To examine this possibility, we immunized WT and
 
plt
 
 mice subcutaneously with OVA in CFA and examined
the numbers of total T cells, CD4
 
1
 
 cells, CD8
 
1
 
 cells, B
cells, and DCs within draining LNs and spleen over subse-
quent days (Fig. 1, B and C). In WT mice, the number of
T cells increases rapidly in LNs after immunization (Fig. 1
B). The number of T cells peaks at day 9 and begins to de-
cline by day 20. Consistent with previous findings, the
number of CD4
 
1
 
 and CD8
 
1
 
 T cells is markedly reduced
in 
 
plt
 
 LNs before immunization. 
 
plt
 
 mice demonstrate al-
most no increase in the number of LN T or B cells 4 d af-
ter immunization. However, by day 9 the number of these
cells has increased markedly over baseline levels. T cell
Figure 1. Contact hypersensi-
tivity response and kinetics of
leukocyte accumulation in LNs
and spleen after immunization.
(A) Mice were sensitized with
150  ml 7% PCl in acetone/olive
oil or vehicle alone, and 2 or 6 d
later, 20 ml of 1% PCl was ap-
plied to the right ear with vehi-
cle alone applied to the left ear.
Ear thickness was measured at
the indicated times after elicita-
tion. Ear swelling was calculated
in comparison to baseline.
Mean  6 SD for four to five
mice are indicated. (B and C)
Cells from draining LNs (B) or
spleen (C) were harvested from
WT (s) or plt (d) mice at day 0,
4, 9, and 20 after immunization.
Cells were counted, stained with
anti–TCR-Cb, anti-CD4, anti-
CD8, anti-B220, anti–I-A, or
anti-CD11c mAb, and analyzed
by flow cytometry. Cell numbers
were calculated from the total
cell number and the percentage of positive cells, and indicated as the number per single LN or spleen. Mean 6 SD for two mice are indicated. Similar re-
sults were obtained in a repeat experiment.210 T Cell Responses in plt Mice
numbers further increase by day 20, with the number of
CD81 cells reaching a level comparable to that seen in WT
mice. Interestingly, the accumulation of B cells in plt LNs
is also reduced in the first 4 d after immunization. The ac-
cumulation of DCs in plt LNs is less than half of that seen
in WT mice but occurs over a similar time course.
Figure 2. Localization of T cells, B cells, and DCs in the draining LNs
and spleen of OVA-immunized mice. Draining popliteal LNs from WT
(A, C, and E) and plt mice (B, D, and F), and spleens from WT (G, I, K,
and M) and plt mice (H, J, L, and N) were harvested at 9 d after immuni-
zation. Frozen sections were stained with mAbs anti-Thy1.2 for T cells
(green in A, B, E, F, G, H, K, and L, or brown in M and N), anti-B220
for B cells (red in A, B, G, and H, green in C, D, I, and J, or blue in M
and N), and anti–DEC-205 for DCs (red in E, F, K, and L). T and B cells
(A, B, G, H, M, and N), B cells and DCs (C, D, I, and J), and T cells and
DCs (E, F, K, and L) are shown. t, T cell zones; b, B cell follicles. Arrows
indicate the subcapsular sinus. Arrowheads indicate splenic bridging chan-
nels. Colocalization signal is indicated as yellow/orange. Bars, 100 mm
(A–L). Original magnification: (M and N) 320.
When spleens are examined, WT mice demonstrate little
increase in the number of splenic T cells at 4 d after immu-
nization. By day 9 there is a modest increase in T cell num-
bers, which falls off by day 20. As shown previously, the
spleens of plt mice contain an increased number of T cells
at baseline (Fig. 1 C). After immunization, T cell numbers
increase rapidly in the spleens of plt mice, with a twofold
increase by day 4 after immunization. These levels remain
elevated through day 9 and return towards baseline by day
20. At baseline, the spleens of plt and WT mice contain a
similar number of DCs. After immunization, DCs gradually
accumulate in the spleens of WT mice, with a peak in-
crease of fourfold seen at day 9. In plt mice, splenic DCs
accumulate more rapidly and to a greater extent than is
seen in WT mice.
Localization of T Cells and DCs after Immunization. Be-
cause CCL21 and CCL19 are believed to contribute to the
proper localization of lymphocytes and DCs within sec-
ondary lymphoid organs, we examined the localization of
these cells after immunization. Frozen LN and spleen sec-
tions were stained with anti-Thy1.2, anti-B220, and anti–
DEC-205 9 d after immunization and examined by confo-
cal microscopy (Fig. 2). In WT LNs, T cells and B cells are
well segregated into T cell zones and follicles with the ma-
jority of colocalization occurring at the intersection of
these areas (Fig. 2 A). In plt LNs, the majority of T cells are
found in the region just beneath the subcapsular sinus and
an increased number of these cells is seen within follicles
(Fig. 2 B). In WT LNs, the vast majority of DCs are found
within the T cell zone (Fig. 2 C) and can be seen to colo-
calize with T cells in this area (Fig. 2 E). In plt LNs, most
DCs are found in the superficial cortex between lymphoid
follicles (Fig. 2 D) and colocalize with T cells in this area
(Fig. 2 F). This region appears to be enlarged compared
with WT mice.
As described previously, plt mice demonstrate several ab-
normalities in splenic architecture (22). Total splenic T cell
numbers are increased 1.5–3-fold, probably due to the ex-
clusion of these cells from LNs. plt mice demonstrate mark-
edly decreased numbers of T cells within white pulp, with
a redistribution of these cells into red pulp and into gaps in
the marginal zone between red and white pulp known as
bridging channels (28, 29). plt mice also demonstrate an in-
creased number of white pulp areas, each of these being211 Mori et al.
much smaller than normal (22). This diffuse overall distri-
bution of T cells within plt relative to WT spleens is not al-
tered after immunization (Fig. 2, M and N), and the con-
centration of these cells remains decreased in any given area
of plt spleen despite their increased total numbers. When
the spleens of immunized WT mice are examined by con-
focal microscopy, both T cells and DCs are found almost
exclusively within T cell zones (Fig. 2, G and I) and display
a strong colocalization signal in this area (Fig. 2 K). In plt
mice, few T cells or DCs are detected in the white pulp
(Fig. 2, H and J). Instead, these cells are concentrated in
bridging channels where they can be seen to colocalize
(Fig. 2 L). Thus, although T cells and DCs each demon-
strate migration defects in plt mice, these defects do not
prevent T cells and DCs from colocalizing after immuniza-
tion. However, this colocalization appears to occur at ab-
normal locations in plt mice.
The Primary T Cell Response in plt/plt Mice. The re-
sponse of plt mice to contact sensitization and the colocal-
ization of T cells and DCs after immunization suggests that
at least some T cell priming occurs in plt mice. To examine
T cell priming directly, we immunized WT and plt mice
subcutaneously with OVA in CFA and analyzed the recall
response of draining LN and splenic T cells upon antigen
restimulation in vitro. 9 d after immunization, draining LN
T cells from plt mice respond well to OVA presented by ir-
radiated WT spleen cells. Unexpectedly, both proliferation
and IL-2 production in T cells from plt mice are greater
than in those from WT mice (Fig. 3 A). These T cell re-
sponses in plt and WT mice are OVA dose dependent (Fig.
3 B). Examination of the curves for T cell proliferation per
number of input cells (Fig. 3 A) reveals a shift to the left in
those of plt mice. This shift suggests that LN preparations
from plt mice contain a higher percentage of OVA-reactive
T cells than those of WT mice. This higher percentage
may be due to the decreased total number of T cells in plt
LNs (see below) but indicates that T cells in the draining
LNs of plt mice are well primed by OVA immunization.
This finding is consistent with the results seen after contact
sensitization. Because antigen presentation appears to be in-
tact in plt mice, in subsequent experiments we performed
in vitro stimulation using LN cells instead of enriched T
cells added to irradiated syngeneic spleen cells. Comparable
results were obtained using this method (Fig. 3 C).
To examine the time course of T cell priming in plt
mice, we immunized plt and WT mice with OVA in CFA,
harvested draining LN and spleen cells at various time
points after immunization, and measured cell proliferation
and IL-2 production after in vitro restimulation with OVA.
The proliferative response of and IL-2 production by LN
cells from WT mice gradually increase between day 2 and
4 after immunization, peak at day 9, and are substantially
diminished by day 20 (Fig. 4 A). LN cells from plt mice
demonstrated a response similar to that of WT cells
through day 9 after immunization. However, this prolifera-
tive response continues to increase until, 20 d after immu-
nization, it is greater than that seen at any time in LN cells
from WT mice. This level of proliferative response is main-
tained for at least 8 wk after immunization. In vitro IL-2
production by plt draining LN cells follows a time course
similar to that of proliferation and is also maintained at high
levels for at least 8 wk.
When the response of splenic T cells are examined, pro-
liferation of and cytokine production by T cells from plt
mice is greater than that seen in WT mice at every time
point examined (Fig. 4 B). In WT mice, the splenic re-
sponse to subcutaneous immunization is modest. IL-2 pro-
duction peaks at day 9 and has begun to decline by day 20.
In plt mice, the proliferative response develops over the
same time course as in WT mice but is greater at all time
points. IL-2 production by plt splenocytes reaches much
higher levels than occurs in WT mice and peaks at day 20.
The above results present T cell responsiveness to in
vitro stimulation using a constant number of input cells.
However, as shown in Fig. 1 B, the number of T cells in
WT and plt lymphoid organs differ markedly. To better
compare the magnitude of T cell responses in the lymphoid
organs of plt and WT mice, T cell proliferative responses
were normalized to a per draining LN or per spleen basis
(Fig. 5). In the draining LNs of WT mice, the total T cell
proliferative response increases rapidly until day 9 after im-
Figure 3. Draining LN T cell responses after OVA immunization.
Mice were immunized subcutaneously with 100 mg OVA in CFA. 9 d
later, T cells purified from pooled draining LNs or pooled draining LN
cells were examined for proliferation and IL-2 production. (A) Sequen-
tially diluted purified draining LN T cells cultured in the presence or ab-
sence of 1,600 mg/ml OVA and 5 3 105 of irradiated BALB/c spleen
cells. (B) 2 3 105 purified T cells cultured with indicated dose of OVA
and 5 3 105 of irradiated spleen cells. (C) Sequentially diluted draining
LN cells (unpurified) were cultured with or without 1,600 mg/ml of
OVA. Proliferation and IL-2 production were assessed as described in
Materials and Methods. Values represent means 6 SD from triplicate
samples. One of two similar experiments is shown.212 T Cell Responses in plt Mice
munization, then quickly returns to near baseline levels
(Fig. 5 A). In the draining LNs of plt mice, the total T cell
proliferative response increases more slowly, peaks at day 20
at a level z60% of that seen in WT mice, then decreases at
a much slower rate than occurs in WT mice. In the spleens
of WT mice, the total T cell proliferative response increases
modestly after immunization, then declines slowly (Fig. 5
B). In comparison, plt mice mount a much greater splenic
T cell response at all time points. This response peaks at day
20 and demonstrates no decrease through 8 wk.
To approximate the total lymphoid organ T cell re-
sponse, we summed the total T cell proliferative responses
from spleen and the four major draining LNs for both WT
and plt mice. As shown in Fig. 5 C, the total lymphoid or-
gan T cell responses in WT and plt mice are surprisingly
similar in the first 9 d after immunization. However, be-
tween days 9 and 20 the total T cell response in plt mice in-
creases dramatically, whereas the response in WT mice de-
clines. Thereafter, the total T cell proliferative responses in
WT and plt mice decline at a similar rate. This leaves the
total T cell response in plt mice markedly elevated relative
to WT mice.
Primary T Cell Response in the Draining LNs of Splenecto-
mized Mice. The delayed LN response in plt mice can be
explained by the decreased ability of naive T cells to enter
the LNs of these animals from the blood. However, this
raises questions about the origin of those T cells that even-
tually accumulate in the draining LNs of plt mice. One
possibility is that T cells enter plt LNs after being activated
at other sites. As the above findings demonstrate, a pre-
dominant site of early T cell activation in plt mice is the
spleen. To evaluate the contribution of splenic activity to
the draining LN response of plt mice, we immunized WT
and plt mice that had received prior splenectomy and mea-
sured the response of draining LN cells to subsequent in
vitro stimulation. When examined 9 and 20 d after subcu-
taneous immunization, prior splenectomy had little effect
on the proliferation of and cytokine production by lym-
phocytes from WT mice (Fig. 6). However, in plt mice T
cell proliferation and cytokine production upon in vitro re-
stimulation were substantially reduced in those animals that
had received prior splenectomy. These findings suggest that
an increased proportion of T cells are primed in the spleens
of plt mice after immunization and these cells then migrate
to draining LNs as the immune response progresses.
T Cell Migration into Draining LNs. T cells entering the
draining LNs of immunized plt mice may reach this site by
two possible routes. First, they may extravasate from the
blood across HEVs. Significant extravasation across HEVs
would imply that chemoattractants or chemokines other
than CCL21 are induced on high endothelial cells during
an immune response. Second, T cells may enter draining
LNs via afferent lymphatics. This would suggest that only
those T cells capable of entering peripheral tissues would
reach draining LNs. To distinguish these possibilities, we
examined the migration of T cells from blood and subcuta-
Figure 4. Time course of
draining LN and splenic T cell
responses after OVA immuniza-
tion. Draining LN cells (A) or
spleen cells (B) were harvested 2,
4, 9, 20, and 56 d after immuni-
zation and cultured at 5 3 105
cells/well with various doses of
OVA. Proliferation and IL-2
production were assessed as de-
scribed in Materials and Meth-
ods. Means 6 SD from triplicate
tests are indicated. Representa-
tive results from three indepen-
dent experiments is shown.213 Mori et al.
neous tissues into the LNs of mice 9 d after immunization.
As shown in Fig. 7, A and B, both resting T cells and T
cells prepared from the draining LNs of immunized mice
migrate well to the LNs of immunized WT recipients with
preferential accumulation in draining versus nondraining
LNs. Activated T cells purified from the spleens of immu-
nized mice (CD45RB2) show a similar pattern of migra-
tion, albeit with a reduced efficiency (Fig. 7 C). When in-
jected into immunized plt mice, the migration of all T cell
populations to LNs is markedly reduced relative to WT
mice (Fig. 7, A–C). This finding is similar to results ob-
tained in nonimmunized plt mice (22) and suggests that no
other factors compensate for the absence of CCL21 on
HEVs after immunization.
To examine the migration of T cells to LNs via lymphat-
ics, cells were injected into footpads and their accumulation
in popliteal and inguinal LNs was examined after 6 h.
When resting T cells are injected into the footpads of non-
immunized mice, few of these cells reach the draining LNs
in either WT or plt mice (Fig. 7 D). In contrast, substantial
numbers of subcutaneously injected T cells reach the drain-
ing LNs of immunized WT mice (Fig. 7, E and F). In plt
mice, this migration is somewhat decreased in the case of
resting T cells but not significantly reduced when draining
LN T cells are injected. These findings demonstrate that
the lymphatic migration of T cells is preserved in plt mice
and suggest that this is the major route by which T cells
reach the draining LNs of immunized plt mice.
Discussion
In a typical primary immune response, presentation of
antigen to naive T cells occurs predominantly within the
specialized microenvironment of the T cell–dependent ar-
eas of secondary lymphoid organs. Although the functional
significance of this anatomic specialization is not known, it
has often been assumed that T cell priming within T cell
zones is required for the proper development of T cell im-
munity. This view has been supported by the lack of con-
tact sensitization responses in both L-selectin– and CCR7-
deficient mice, defects attributed to the severely impaired
migration of naive T cells (and in the case of CCR72/2
Figure 5. Time course of total draining LN, total splenic, and total
lymphoid organ T cell proliferative responses after OVA immunization.
Results calculated on the basis of data from Fig. 4. Total proliferative re-
sponse per draining LN (A) or per spleen (B) was calculated by multiply-
ing the proliferation per cell at 1.6 mg/ml of OVA (derived from Fig. 4)
by the mean LN or spleen cell number at the indicated times after immu-
nization. (C) The total lymphoid organ T cell proliferative response was
calculated by summing the responses of four draining LNs (two popliteal
and two inguinal LNs) and spleen.
Figure 6. Effect of prior splenec-
tomy on draining LN T cell responses.
Spleens were removed from WT (s)
and plt mice (d) at least 9 d before im-
munization. Splenectomized and nor-
mal mice were immunized subcutane-
ously with 100 mg OVA in CFA.
Draining LN cells were harvested
from mice at day 9 (A–D) or day 20
(E–H) after immunization and their
proliferation and IL-2 production
were measured as in the legend to Fig.
4. Means 6 SD from triplicate tests are
indicated.214 T Cell Responses in plt Mice
mice, activated DCs) into the T cell zones of these animals
(27, 30, 31). Like CCR72/2 mice, plt mice demonstrate
impaired migration of naive T cells and activated DCs into
T cell zones (21, 22, 25), and therefore could be expected
to lack T cell responses.
In contrast to this expectation, we find that T cell prim-
ing after antigen challenge is intact in plt mice. This dem-
onstrated by two findings. First, plt mice respond well to
contact sensitization (Fig. 1). Second, T cells from the
draining LNs and spleens of immunized plt mice demon-
strate robust antigen-specific proliferation and IL-2 pro-
duction after in vitro stimulation (Figs. 2 and 3). When an-
tigen-specific T cell proliferation is normalized to account
for differing cell numbers, the overall magnitude of T cell
response in plt mice equals or exceeds that seen in WT
mice at every time point examined. These findings demon-
strate that the abnormal immune responses seen in plt mice
are not due to a failure of T cell priming.
Although T cell immune responses are intact in plt mice,
they differ from those seen in WT mice in several respects.
First, as shown by their response to contact sensitization, T
cell responses in at least some peripheral site of plt mice are
delayed. Second, a portion of T cell responses, especially at
early time points, appear to be shifted from LNs to spleen.
This shift is seen in the accumulation of lymphocytes and
DCs in LNs and spleen after immunization, in the total
proliferative response to immunization in LNs and spleen,
and in the decreased proliferative capacity of T cells recov-
ered from the draining LNs of plt mice that have received
prior splenectomy (Fig. 1, B and C, and Figs. 5 and 6).
Third, and most striking, T cell responses in plt mice are
markedly prolonged. T cells from LNs and spleens of plt
mice proliferate and express IL-2 in response to antigens for
at least 8 wk after immunization, whereas this response in
WT mice has largely subsided after 20 d (Figs. 4 and 5). We
have also observed a prolonged increase in number of
Vb8.21 T cells in the draining LNs of plt mice in response
to viral superantigens when infected with mouse mammary
tumor virus (32; and H. Nakano, unpublished observa-
tion).
Associated with these abnormalities in immune response,
plt mice display several abnormalities in leukocyte migra-
tion after antigen challenge. First, plt mice demonstrate no
increase in the number of T and B cells within draining
LNs in the first 4 d of an immune response (Fig. 1 B). After
day 4 after immunization, T and B cell numbers in draining
plt LNs increase markedly (Fig. 1 B). This implies that a
second phase of T cell expansion occurs in immunized LNs
that is dependent on neither CCL21 nor CCL19. The in-
crease in T cell numbers during this phase may be due to
the local proliferation of T cells, to T cell emigration from
the blood, and to the entry of T cells into immunized LNs
via lymphatics. The poor migration of T cells into immu-
nized LNs from the blood and the effective migration of
these cells into LNs from the foot pad suggest that lym-
phatics are the predominant route by which T cells enter
plt LNs after immunization (Fig. 7).
The second leukocyte migration abnormality seen in im-
munized plt mice is the abnormal trafficking of DCs. plt
mice demonstrate a decreased accumulation of DCs in
draining LNs after immunization (Fig. 1 B) that is similar to
the defect seen after contact sensitization with FITC (25).
Although DCs have been demonstrated to enter the lym-
phatics of plt mice, the assay used is not quantitative and the
proportion of DCs that enter the lymphatics of plt mice af-
ter immunization is not known. Decreased DC entry into
the lymphatics of plt mice is suggested by the decreased ex-
pression of CCL21 at this site (12). plt mice also appear to
have a defect in the migration of DCs from the subcapsular
space into the LN cortex (25). Thus, it is possible that a
portion of the DCs mobilized from the peripheral tissues of
plt mice bypass draining LNs, enter the circulation, and are
deposited in the spleen. This is one possible explanation for
the increased accumulation of these cells in spleen (Fig. 1
C) and the increased T cell proliferation in this organ after
immunization. We have attempted to examine the direct
Figure 7. T cell migration into LNs through HEV vs.
afferent lymphatics. T cells from nonimmunized mice (na-
ive T), draining LN T cells from OVA-immunized mice
(dLN T), or activated (CD45RB2) splenic T cells from
OVA-immunized mice (CD45RB2 T) were enriched, la-
beled with BCECF or CMFDA, and injected into WT
(cross-hatched bars) or plt (black bars) recipients. All panels
show the percentage of injected cells recovered from the
draining or nondraining LNs of recipients. (A) 107 naive T
cells injected by tail vein (i.v.) into immunized (imm)
mice. (B) 1.4 3 107 draining LN T cells injected by tail
vein into immunized mice. (C) 107 CD45RB2 splenic T
cells injected by tail vein into immunized mice. (D) 107
naive T cells injected into the foot pads (s.c.) of nonimmu-
nized mice. (E) 107 naive T cells injected into the foot pads
of immunized mice. (F) 107 draining LN T cells injected
into the foot pads of immunized mice. All immunized
mice were used at day 9 after immunization. 6 h after in-
jection of labeled T cells, draining and nondraining LNs
were collected and BCECF- or CMFDA-positive cells an-
alyzed by flow cytometry. Percentage of input cells recovered per LN was calculated from total cell count and percentage of the fluorescence-positive
cells, and mean 6 SD from three mice are indicated. *P , 0.05, **P , 0.01, ***P , 0.001 for plt vs. WT. Pop/Ing, popliteal/inguinal; Cer/Axi/Bra,
cervical/axillary/brachial.215 Mori et al.
migration of labeled DCs from sensitized skin to spleen,
but have been unable to detect such a phenomenon (data
not shown). This negative result does not rule out the mi-
gration of DCs from skin to LNs in plt mice, but suggests
that the frequency of labeled or Ag-bearing DCs among
splenocytes is low, and that the increase in DC numbers
seen in plt mice after immunization may be due to a non-
specific mobilization of these cells from peripheral sites.
plt mice also demonstrate an abnormality in leukocyte
localization in that T cell–DC interactions occur outside
the normal confines of the T cell zone (Fig. 2). In plt LNs,
T cells and DCs colocalize in the very superficial cortex ad-
jacent to the subcapsular sinus. In plt spleen, T cells and
DCs colocalize in bridging channels that span openings in
the marginal zone between red and white pulp. Although
our studies do not specifically identify T cells responding to
Ag, the concentration of T cell–DC interactions at the
above locations suggest that these are the sites where Ag
presentation occurs. These data also suggest that the ex-
pression of CCL19 by DCs is not essential for T cell–DC
interactions, as plt mice lack a functional CCL19 gene (12,
14). As we have shown previously, splenic bridging chan-
nels and the superficial cortex of LNs are the sites where
most DCs are found in these tissues of nonimmunized plt
mice (25). This would suggest that these areas represent
points at which the normal migration of DCs into T cell
zones is blocked in plt mice. The accumulation of T cells at
these sites after immunization may represent a similar
blockade in a population of cells following the same migra-
tion route. Alternatively, activated DCs may be capable of
attracting T cells to areas in which they, the DCs, are con-
centrated.
At present, there are several possible explanations for the
abnormal immune responses observed in plt mice. First, the
plt phenotype may be due to an altered kinetics of immune
response. Defects in leukocyte migration may lead to a de-
creased intensity of antigen presentation but an increase in
the period of time over which antigen presentation occurs.
This may explain the persistence of activated T cells in plt
mice in that intensity of antigenic stimulation has been
demonstrated to affect the magnitude of T cell contraction
(33, 34). This may also explain the sensitivity of plt mice to
viral infection (25), as they may not begin to clear virus un-
til substantial viral loads have developed. Second, the ab-
normal location of T cell priming may alter immune re-
sponses in plt mice. Aside from assisting in the efficient
selection and stimulation of Ag-specific T cells, it is likely
that T cell zones provide cytokines or growth factors that
influence the development of T cell response (33). Because
plt mice prime T cells outside this environment, these cells
may not receive stimuli that normally contribute to a prop-
erly regulated immune response. Finally, it is possible that
the abnormalities seen in plt mice are due to an alteration in
antigen-presenting cells. T cell priming in plt mice appears
to occur in areas that normally contain CD82CD11b1
“myeloid” DCs rather than CD81CD11b2 “lymphoid”
DCs (35). This suggests that antigen presentation in plt
mice may occur predominately via newly migrated my-
eloid DCs rather than interdigitating lymphoid DCs.
Whether representing a separate lineage or merely a differ-
ent activation state, lymphoid DCs have been regarded as
possible regulatory cells. These cells have been shown to
induce apoptosis of antigen-specific T cells after transient
proliferation (36, 37). Thus, antigen presentation by acti-
vated myeloid DCs is consistent with the enhanced T cell
responses in plt mice. The finding that survival of activated
superantigen-specific T cells is prolonged in plt mice sup-
ports this possibility, as superantigens normally induce
prompt apoptosis of antigen-specific T cells (38). We did
not specifically distinguish these two DC populations in
our localization studies, as DEC-205 can be expressed by
both cell types under activated condition (39–41). Further
characterization of the DC populations in plt mice and the
response of T cells stimulated by these DCs are underway.
It is possible that the prolonged activation of T cells in plt
mice leads to other alterations in immune response. As an
example, we have found that levels of OVA-specific IgG2a
in plt mice are enhanced for up to 5 mo after immuniza-
tion. However, levels of OVA-specific IgG1, IgM, and
IgG2b are altered in a more complex manner, suggesting a
possible alteration in the balance of Th1 versus Th2 cyto-
kines. A characterization of humoral responses in plt mice
will be reported separately (unpublished observations).
Our findings of enhanced T cell responses in plt mice are
unexpected given the reported lack of primary T cell re-
sponses in CCR72/2 mice. Although T cell responses in
CCR72/2 mice have not been characterized as thoroughly
as those in plt mice, it appears that those in plt mice are
more robust. The reason for this is most likely related to
differences in T cell and DC migration. In general, ab-
normalities in leukocyte migration are more severe in
CCR72/2 than in plt mice (22, 25, 27). The migration of
activated DCs is decreased to a lessor extent in plt than in
CCR72/2 mice, probably due to the preserved expression
of CCL21-leu in their lymphatic endothelium (12). Low
level expression of CCL21 may stimulate the entry of DCs
into plt LNs at a level that is sufficient to support primary T
cell responses. In mice lacking CCR7, this function is ab-
sent, and T cell responses are likely to be more severely im-
paired. Alternatively, it remains possible that a gene other
than CCL21 and CCL19 is responsible for the differences
observed in plt and CCR72/2 mice. Although we have
partially characterized the plt deletion and confirmed the
presence of most genes known to be in this region (Gunn,
M.D., unpublished observations), we cannot rule out the
possibility that an unknown gene is present in this region, is
deleted in the plt mutation, and leads to some of the abnor-
malities we observe.
In summary, we demonstrate that plt mice, which lack
expression of CCL21 and CCL19 in lymphoid organs, are
capable of mounting T cell immune responses in spite of
severe defects in T cell and DC migration and localization.
In addition, T cell activity in plt mice persists at high levels
for at least 8 wk after immunization. The mechanisms un-
derlying these abnormalities are not yet known, but may
involve defects in the localization of specific DC popula-216 T Cell Responses in plt Mice
tions. plt mice should prove to be an excellent model to
study the manner in which chemokines may regulate the
magnitude, timing, and quality of immune response.
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